Technical Analysis for ACHV - Achieve Life Sciences, Inc.

Grade Last Price % Change Price Change
grade D 1.81 2.26% 0.04
ACHV closed up 2.26 percent on Friday, August 16, 2019, on 46 percent of normal volume.
5 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Up
See historical ACHV trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Doji - Bearish? Reversal 0.00%
Doji - Bullish? Reversal 0.00%
BB Squeeze + Upper Band Touch Range Contraction 0.00%
Outside Day Range Expansion 0.00%
Upper Bollinger Band Touch Strength 0.00%
20 DMA Resistance Bearish 2.26%
Bollinger Band Squeeze Range Contraction 2.26%
Inside Day Range Contraction 2.26%

Older signals for ACHV ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Read My Charts!
Configure default chart indicators
Basic chart:
Profile
Achieve Life Sciences, Inc., a biopharmaceutical company, develops and commercializes therapies that address treatment resistance in cancer patients. It is developing Apatorsen to block the production of heat shock protein 27, a cell-survival protein expressed in various types of cancers, including bladder, prostate, breast, pancreatic, and non-small cell lung cancer. The company is headquartered in Bothell, Washington.
Biopharmaceutical Cancer Cancers Prostate Cancer Breast Cancer Non Small Cell Lung Cancer Oncolytics Biotech
Is ACHV a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Aug 9 Achieve Life Sciences, Inc. (ACHV) CEO Rick Stewart on Q2 2019 Results - Earnings Call Transcript
Aug 8 /C O R R E C T I O N -- Achieve Life Sciences, Inc./
Aug 8 Achieve Life Sciences EPS beats by $0.06
Aug 8 The Daily Biotech Pulse: Glaukos To Buy Avedro, Mixed Adcom Vote For Gilead, Dynavax Offering
Aug 3 The Week Ahead In Biotech: Focus On Earnings Deluge, Mid-Year Clinical Trial Readouts
Jul 30 Achieve Life Sciences to Announce Second Quarter 2019 Financial Results and Host Conference Call and Webcast on August 8, 2019
Jul 23 Achieve extends NIH collaboration to advance cytisinicline for smoking cessation
Jul 23 Achieve Life Sciences Extends Collaboration with the National Institutes of Health to Advance the Development of Cytisinicline for Smoking Cessation
Jul 10 Did You Manage To Avoid Achieve Life Sciences's (NASDAQ:ACHV) Painful 55% Share Price Drop?
Jun 21 Achieve Life Sciences Says Mid-Stage Data For Smoking Cessation Drug Accepted For Presentation At Conference
See more ACHV news...
Indicators
Indicator Value
52 Week High 5.25
52 Week Low 1.045
Average Volume 205,583
200-Day Moving Average 2.3877
50-Day Moving Average 2.0728
20-Day Moving Average 1.815
10-Day Moving Average 1.784
Average True Range 0.1549
ADX 28.41
+DI 20.3684
-DI 20.9316
Chandelier Exit (Long, 3 ATRs ) 1.5005
Chandelier Exit (Short, 3 ATRs ) 2.0747
Upper Bollinger Band 1.9261
Lower Bollinger Band 1.7039
Percent B (%b) 0.48
BandWidth 12.242424
MACD Line -0.0868
MACD Signal Line -0.1183
MACD Histogram 0.0315
Fundamentals Value
Market Cap 19.81 Million
Num Shares 10.9 Million
EPS -56.38
Price-to-Earnings (P/E) Ratio -0.03
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.16
Resistance 3 (R3) 2.16 2.05 2.10
Resistance 2 (R2) 2.05 1.96 2.05 2.08
Resistance 1 (R1) 1.93 1.91 1.99 1.93 2.06
Pivot Point 1.82 1.82 1.85 1.82 1.82
Support 1 (S1) 1.70 1.73 1.76 1.70 1.56
Support 2 (S2) 1.59 1.68 1.59 1.54
Support 3 (S3) 1.47 1.59 1.52
Support 4 (S4) 1.47